Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 5 |
NetGPI | no | yes: 0, no: 5 |
Related structures:
AlphaFold database: A4HLP9
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 141 | 145 | PF00656 | 0.511 |
CLV_NRD_NRD_1 | 208 | 210 | PF00675 | 0.444 |
CLV_NRD_NRD_1 | 278 | 280 | PF00675 | 0.524 |
CLV_NRD_NRD_1 | 77 | 79 | PF00675 | 0.525 |
CLV_PCSK_KEX2_1 | 208 | 210 | PF00082 | 0.444 |
CLV_PCSK_KEX2_1 | 278 | 280 | PF00082 | 0.524 |
CLV_PCSK_KEX2_1 | 77 | 79 | PF00082 | 0.672 |
CLV_PCSK_SKI1_1 | 191 | 195 | PF00082 | 0.543 |
CLV_PCSK_SKI1_1 | 226 | 230 | PF00082 | 0.469 |
CLV_PCSK_SKI1_1 | 246 | 250 | PF00082 | 0.573 |
CLV_PCSK_SKI1_1 | 251 | 255 | PF00082 | 0.669 |
CLV_PCSK_SKI1_1 | 281 | 285 | PF00082 | 0.583 |
CLV_PCSK_SKI1_1 | 77 | 81 | PF00082 | 0.653 |
CLV_Separin_Metazoa | 132 | 136 | PF03568 | 0.366 |
DEG_APCC_DBOX_1 | 280 | 288 | PF00400 | 0.507 |
DOC_MAPK_FxFP_2 | 289 | 292 | PF00069 | 0.479 |
DOC_PP1_RVXF_1 | 135 | 141 | PF00149 | 0.511 |
DOC_PP4_FxxP_1 | 289 | 292 | PF00568 | 0.479 |
DOC_USP7_MATH_1 | 142 | 146 | PF00917 | 0.516 |
DOC_USP7_MATH_1 | 164 | 168 | PF00917 | 0.626 |
LIG_14-3-3_CanoR_1 | 112 | 116 | PF00244 | 0.373 |
LIG_14-3-3_CanoR_1 | 135 | 141 | PF00244 | 0.511 |
LIG_14-3-3_CanoR_1 | 226 | 236 | PF00244 | 0.600 |
LIG_14-3-3_CanoR_1 | 246 | 254 | PF00244 | 0.466 |
LIG_14-3-3_CanoR_1 | 260 | 268 | PF00244 | 0.611 |
LIG_14-3-3_CanoR_1 | 269 | 274 | PF00244 | 0.639 |
LIG_14-3-3_CanoR_1 | 5 | 14 | PF00244 | 0.484 |
LIG_14-3-3_CanoR_1 | 56 | 66 | PF00244 | 0.414 |
LIG_APCC_ABBA_1 | 127 | 132 | PF00400 | 0.381 |
LIG_BRCT_BRCA1_1 | 287 | 291 | PF00533 | 0.490 |
LIG_CaM_IQ_9 | 258 | 273 | PF13499 | 0.614 |
LIG_deltaCOP1_diTrp_1 | 12 | 20 | PF00928 | 0.473 |
LIG_FHA_1 | 1 | 7 | PF00498 | 0.467 |
LIG_FHA_1 | 122 | 128 | PF00498 | 0.512 |
LIG_FHA_1 | 58 | 64 | PF00498 | 0.387 |
LIG_FHA_1 | 88 | 94 | PF00498 | 0.443 |
LIG_FHA_2 | 43 | 49 | PF00498 | 0.501 |
LIG_LIR_Apic_2 | 288 | 294 | PF02991 | 0.473 |
LIG_LIR_Gen_1 | 122 | 130 | PF02991 | 0.522 |
LIG_LIR_Gen_1 | 139 | 148 | PF02991 | 0.341 |
LIG_LIR_Gen_1 | 45 | 54 | PF02991 | 0.532 |
LIG_LIR_Gen_1 | 94 | 105 | PF02991 | 0.377 |
LIG_LIR_Nem_3 | 12 | 17 | PF02991 | 0.529 |
LIG_LIR_Nem_3 | 122 | 126 | PF02991 | 0.495 |
LIG_LIR_Nem_3 | 139 | 143 | PF02991 | 0.334 |
LIG_LIR_Nem_3 | 263 | 268 | PF02991 | 0.617 |
LIG_LIR_Nem_3 | 45 | 50 | PF02991 | 0.645 |
LIG_LIR_Nem_3 | 94 | 100 | PF02991 | 0.517 |
LIG_PCNA_PIPBox_1 | 13 | 22 | PF02747 | 0.389 |
LIG_PDZ_Class_2 | 292 | 297 | PF00595 | 0.464 |
LIG_SH2_STAP1 | 119 | 123 | PF00017 | 0.474 |
LIG_SH2_STAP1 | 130 | 134 | PF00017 | 0.406 |
LIG_SH2_STAT5 | 43 | 46 | PF00017 | 0.610 |
LIG_TRAF2_1 | 129 | 132 | PF00917 | 0.379 |
LIG_UBA3_1 | 216 | 224 | PF00899 | 0.561 |
LIG_UBA3_1 | 239 | 243 | PF00899 | 0.505 |
MOD_CK1_1 | 175 | 181 | PF00069 | 0.468 |
MOD_CK1_1 | 182 | 188 | PF00069 | 0.408 |
MOD_CK1_1 | 227 | 233 | PF00069 | 0.615 |
MOD_CK1_1 | 272 | 278 | PF00069 | 0.514 |
MOD_CK2_1 | 119 | 125 | PF00069 | 0.521 |
MOD_CK2_1 | 42 | 48 | PF00069 | 0.504 |
MOD_Cter_Amidation | 75 | 78 | PF01082 | 0.377 |
MOD_GlcNHglycan | 179 | 182 | PF01048 | 0.583 |
MOD_GlcNHglycan | 22 | 25 | PF01048 | 0.524 |
MOD_GlcNHglycan | 233 | 236 | PF01048 | 0.605 |
MOD_GlcNHglycan | 255 | 259 | PF01048 | 0.702 |
MOD_GlcNHglycan | 262 | 265 | PF01048 | 0.547 |
MOD_GSK3_1 | 111 | 118 | PF00069 | 0.467 |
MOD_GSK3_1 | 172 | 179 | PF00069 | 0.599 |
MOD_GSK3_1 | 224 | 231 | PF00069 | 0.476 |
MOD_GSK3_1 | 256 | 263 | PF00069 | 0.525 |
MOD_NEK2_1 | 111 | 116 | PF00069 | 0.425 |
MOD_NEK2_1 | 163 | 168 | PF00069 | 0.644 |
MOD_NEK2_1 | 172 | 177 | PF00069 | 0.540 |
MOD_NEK2_1 | 20 | 25 | PF00069 | 0.553 |
MOD_NEK2_1 | 228 | 233 | PF00069 | 0.538 |
MOD_NEK2_1 | 254 | 259 | PF00069 | 0.590 |
MOD_NEK2_1 | 58 | 63 | PF00069 | 0.431 |
MOD_NEK2_1 | 92 | 97 | PF00069 | 0.449 |
MOD_PK_1 | 269 | 275 | PF00069 | 0.509 |
MOD_PKA_2 | 111 | 117 | PF00069 | 0.373 |
MOD_PKA_2 | 136 | 142 | PF00069 | 0.510 |
MOD_PKA_2 | 164 | 170 | PF00069 | 0.659 |
MOD_Plk_1 | 173 | 179 | PF00069 | 0.538 |
MOD_Plk_1 | 93 | 99 | PF00069 | 0.472 |
MOD_Plk_2-3 | 192 | 198 | PF00069 | 0.418 |
MOD_Plk_2-3 | 42 | 48 | PF00069 | 0.504 |
MOD_Plk_4 | 111 | 117 | PF00069 | 0.424 |
TRG_DiLeu_BaEn_1 | 65 | 70 | PF01217 | 0.505 |
TRG_DiLeu_BaEn_2 | 74 | 80 | PF01217 | 0.513 |
TRG_DiLeu_BaLyEn_6 | 235 | 240 | PF01217 | 0.559 |
TRG_DiLeu_BaLyEn_6 | 64 | 69 | PF01217 | 0.413 |
TRG_ENDOCYTIC_2 | 130 | 133 | PF00928 | 0.630 |
TRG_ENDOCYTIC_2 | 17 | 20 | PF00928 | 0.527 |
TRG_ENDOCYTIC_2 | 47 | 50 | PF00928 | 0.654 |
TRG_ER_diArg_1 | 134 | 137 | PF00400 | 0.501 |
TRG_ER_diArg_1 | 268 | 271 | PF00400 | 0.638 |
TRG_ER_diArg_1 | 277 | 279 | PF00400 | 0.541 |
TRG_ER_diArg_1 | 77 | 79 | PF00400 | 0.525 |
TRG_Pf-PMV_PEXEL_1 | 191 | 196 | PF00026 | 0.541 |
TRG_Pf-PMV_PEXEL_1 | 5 | 9 | PF00026 | 0.454 |
TRG_Pf-PMV_PEXEL_1 | 67 | 72 | PF00026 | 0.500 |
TRG_Pf-PMV_PEXEL_1 | 78 | 83 | PF00026 | 0.531 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3S7X6V8 | Leishmania donovani | 71% | 100% |
E9AHN7 | Leishmania infantum | 71% | 100% |
E9B424 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 71% | 100% |
Q4Q400 | Leishmania major | 71% | 100% |